Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein E/endothelial nitric oxide synthase double knockout mice

被引:131
作者
Chen, JQ
Kuhlencordt, PJ
Astern, J
Gyurko, R
Huang, PL
机构
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
arteriosclerosis; nitric oxide synthase; aneurysm; hypertension; hydralazine;
D O I
10.1161/hc4501.099729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Apolipoprotein E (apoE)/endothelial nitric oxide synthase (eNOS) double knockout (DKO) mice demonstrate accelerated atherosclerosis and develop abdominal aortic aneurysms and aortic dissection, suggesting a role for eNOS in suppressing atherogenesis. To test whether accelerated atherosclerosis and aortic aneurysms were due to hypertension, we administered hydralazine to male apoE/eNOS DKO mice to reduce blood pressure. Methods and Results-Male apoE/eNOS DKO mice were treated with hydralazine in their drinking water (250 mg/L) using a dose that lowers the blood pressure to levels seen in apoE KO mice. The mice were fed a Western-type diet for 16 weeks, and lesion formation was assessed by inspection of the vessel and staining with Sudan IV. Hydralazine-treated, normotensive male apoE/eNOS DKO mice developed increased aortic lesion areas (30.0 +/-2.8%, n=11) compared with male apoE KO mice (14.6 +/-0.8%, n=7). The extent of lesion formation was not significantly different from male apoE/eNOS DKO mice that were not given hydralazine (28.3 +/-3.1%, n=9). Four of 11 hydralazine-treated male apoE/eNOS DKO mice developed abdominal aortic aneurysms. Conclusions-Hypertension is not required for the accelerated atherosclerosis seen in apoE/eNOS DKO animals, and control of hypertension during a 16-week period does not prevent aortic aneurysm formation.
引用
收藏
页码:2391 / 2394
页数:4
相关论文
共 15 条
  • [1] Modulation of mouse cardiac function in vivo by eNOS and ANP
    Gyurko, R
    Kuhlencordt, P
    Fishman, MC
    Huang, PL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (03): : H971 - H981
  • [2] The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice
    Hayek, T
    Attias, J
    Coleman, R
    Brodsky, S
    Smith, J
    Breslow, JL
    Keidar, S
    [J]. CARDIOVASCULAR RESEARCH, 1999, 44 (03) : 579 - 587
  • [3] HYPERTENSION IN MICE LACKING THE GENE FOR ENDOTHELIAL NITRIC-OXIDE SYNTHASE
    HUANG, PL
    HUANG, ZH
    MASHIMO, H
    BLOCH, KD
    MOSKOWITZ, MA
    BEVAN, JA
    FISHMAN, MC
    [J]. NATURE, 1995, 377 (6546) : 239 - 242
  • [4] Lisinopril reduces left ventricular hypertrophy and cardiac polyamine concentrations without a reduction in left ventricular wan stress in transgenic Tsukuba hypertensive mice
    Kai, T
    Ishikawa, K
    [J]. HYPERTENSION RESEARCH, 2000, 23 (06) : 625 - 631
  • [5] Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice
    Kauser, K
    Da Cunha, V
    Fitch, R
    Mallari, C
    Rubanyi, GM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (05): : H1679 - H1685
  • [6] Enhanced atherosclerosis and kidney dysfunction in eNOS-/-Apo-/- mice are ameliorated by enalapril treatment
    Knowles, JW
    Reddick, RL
    Jennette, JC
    Shesely, EG
    Smithies, O
    Maeda, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (04) : 451 - 458
  • [7] Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice
    Kuhlencordt, PJ
    Gyurko, R
    Han, F
    Scherrer-Crosbie, M
    Aretz, TH
    Hajjar, R
    Picard, MH
    Huang, PL
    [J]. CIRCULATION, 2001, 104 (04) : 448 - 454
  • [8] LEFER AM, 1993, AGENT ACTION SUPPL, V41, P127
  • [9] NITRIC-OXIDE (NO) DONOR MOLECULES - EFFECT OF NO RELEASE RATE ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION IN-VITRO
    MOORADIAN, DL
    HUTSELL, TC
    KEEFER, LK
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (04) : 674 - 678
  • [10] APOE-DEFICIENT MICE DEVELOP LESIONS OF ALL PHASES OF ATHEROSCLEROSIS THROUGHOUT THE ARTERIAL TREE
    NAKASHIMA, Y
    PLUMP, AS
    RAINES, EW
    BRESLOW, JL
    ROSS, R
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (01): : 133 - 140